---
$id: https://graph.org.ai/products/commodity/51111754
$type: Product
source: UNSPSC
code: "51111754"
title: "Mitonafide"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mitonafide

**UNSPSC Code**: 51111754
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an intercalating agent with the molecular formula C16H15N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06Q0V17SI9, chemically known as 2-((dimethylamino)ethyl)-2,3-dihydro-5-nitro-2-azaphenalen-1,3-dion but generally known as mitonafide, which bears US NIH Compound Identifier 41202. European Medicines Agency schedules Mitonafide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09007MIG. The term MITONAFIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). MITONAFIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mitonafide under HS 29251995 and SITC 51482. As of Q4 2014, MITONAFIDE remains the US FDA Preferred Term for this commodity. Mitonafide bears US NLM identifiers UMLS ID C0066614 and NCI Concept Code C66165. SMILES: O=C1[NH]C(=O)C2C3C1C(CCN(C)C)CCC3C([N](=O)O)CC2.

